Cosmo N.V.
CMHC · SIX · CHF
CHF 51.60
−0.30 −0.58%todayNot financial advice.
- Open
- 51.60
- Day range
- 51.40 - 53.10
- 52-week range
- 49.00 - 129.40
- Volume
- 5.6K
- Market cap
- 1.06B
- P/E ratio
- —
- EPS
- -0.43
- Dividend yield
- 3.72%
- Beta
- 1.46
Performance
W
0.00%
1M
−7.86%
3M
−18.10%
6M
−46.03%
YTD
−51.78%
Y
−20.74%
5Y
−27.02%
All
+152.32%
In the news
Oct 19
Cosmo N.V. Gel Reaches Phase 2 Remission Endpoint in Ulcerative Colitis Trial
Cosmo N.V. reported Phase 2 success for its topical rifamycin gel in ulcerative colitis, clearing a key milestone ahead of Phase 3 regulatory talks.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/SIX-CMHC" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Cosmo N.V. (CMHC) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/SIX-CMHC">CMHC stock price</a> by FreeTheAI Stocks</p>